Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6421 AL 6435

Pathological Mechanisms and Molecular Imaging Advances in Alzheimer's Disease

Liu C, Meng Y, Liu R, Wang Z, Zhao H.

Clin Interv Aging. 2025 Sep 15;20:1583-1603. doi: 10.2147/CIA.S534015. eCollection 2025.

Resilience mechanisms underlying Alzheimer's disease

Chew CS, Lee JY, Ng KY, Koh RY, Chye SM.

Metab Brain Dis. 2025 Jan 6;40(1):86. doi: 10.1007/s11011-024-01507-4.

Modulating effects of fitness and physical activity on Alzheimer's disease: Implications from a six-month randomized controlled sports intervention

David S, Costa AS, Hohenfeld C, Romanzetti S, Mirzazade S, Pahl J, Haberl L, Schneider KM, Kilders A, Eggermann T, Trautwein C, Hildebrand F, Schulz JB, Reetz K, Haeger A.

J Alzheimers Dis. 2025 Jan;103(2):552-569. doi: 10.1177/13872877241303764. Epub 2025 Jan 15.

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease

Salloway S, Wojtowicz J, Voyle N, Lane CA, Klein G, Lyons M, Rossomanno S, Mazzo F, Bullain S, Barkhof F, Bittner T, Schneider A, Grundman M, Aldea R, Boada M, Smith J, Doody R.

JAMA Neurol. 2025 Jan 1;82(1):19-29. doi: 10.1001/jamaneurol.2024.3937.

A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research

Iaccarino L, Burnham SC, Tunali I, Wang J, Navitsky M, Arora AK, Pontecorvo MJ.

Neuroimage Clin. 2025;46:103765. doi: 10.1016/j.nicl.2025.103765. Epub 2025 Mar 10.

Traditional Chinese Medicine for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Chen Y, Zhang D, Chen T, Zhao L, Wen L, Hou R.

Am J Chin Med. 2025;53(1):1-15. doi: 10.1142/S0192415X25500016. Epub 2025 Feb 21.

Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms

Greenberg SM, Bax F, van Veluw SJ.

Nat Rev Neurol. 2025 Apr;21(4):193-203. doi: 10.1038/s41582-024-01053-8. Epub 2025 Jan 10.

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

Macfarlane S, Grimmer T, Teo K, O'Brien TJ, Woodward M, Grunfeld J, Mander A, Brodtmann A, Brew BJ, Morris P, Short C, Kurrle S, Lai R, Bharadwaj S, Drysdale P, Sturm J, Lewis SJG, Barton D, Kalafatis C, Sharif S, Perry R, Mannering N, MacSweeney JE, Pearson S, Evans C, Krishna V, Thompson A, Munisamy M, Bhatt N, Asher A, Connell S, Lynch J, Rutgers SM, Dautzenberg PL, Prins N, Oschmann P, Frölich L, Tacik P, Peters O, Wiltfang J, Henri-Bhargava A, Smith E, Pasternak S, Frank A, Chertkow H, Ingram J, Hsiung GR, Brittain R, Tartaglia C, Cohen S, Villa LM, Gordon E, Jubault T, Guizard N, Tucker A, Kaufmann WE, Jin K, Chezem WR, Missling CU, Sabbagh MN.

J Prev Alzheimers Dis. 2025 Jan;12(1):100016. doi: 10.1016/j.tjpad.2024.100016. Epub 2025 Jan 1.

Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities

Cogswell PM, Andrews TJ, Barakos JA, Barkhof F, Bash S, Benayoun MD, Chiang GC, Franceschi AM, Jack CR Jr, Pillai JJ, Poussaint TY, Raji CA, Ramanan VK, Tanabe J, Tanenbaum L, Whitlow CT, Yu FF, Zaharchuk G, Zeinah M, Benzinger TS; ASNR Alzheimer, ARIA, and Dementia Study Group.

AJNR Am J Neuroradiol. 2025 Jan 8;46(1):24-32. doi: 10.3174/ajnr.A8469.

Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

Rabinovici GD, Knopman DS, Arbizu J, Benzinger TLS, Donohoe KJ, Hansson O, Herscovitch P, Kuo PH, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway SP, Weber CJ, Carrillo MC, Johnson KA.

Alzheimers Dement. 2025 Jan;21(1):e14338. doi: 10.1002/alz.14338. Epub 2025 Jan 8.

Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy

Wolk DA, Nelson PT, Apostolova L, Arfanakis K, Boyle PA, Carlsson CM, Corriveau-Lecavalier N, Dacks P, Dickerson BC, Domoto-Reilly K, Dugger BN, Edelmayer R, Fardo DW, Grothe MJ, Hohman TJ, Irwin DJ, Jicha GA, Jones DT, Kawas CH, Lee EB, Lincoln K, Maestre GE, Mormino EC, Onyike CU, Petersen RC, Rabinovici GD, Rademakers R, Raman R, Rascovsky K, Rissman RA, Rogalski E, Scheltens P, Sperling RA, Yang HS, Yu L, Zetterberg H, Schneider JA.

Alzheimers Dement. 2025 Jan;21(1):e14202. doi: 10.1002/alz.14202. Epub 2025 Jan 14.

A multifactorial lens on risk factors promoting the progression of Alzheimer's disease

Parker J, Moris JM, Goodman LC, Paidisetty VK, Vanegas V, Turner HA, Melgar D, Koh Y.

Brain Res. 2025 Jan 1;1846:149262. doi: 10.1016/j.brainres.2024.149262. Epub 2024 Oct 5.

Effectiveness of community-based health education on modifiable risk factors for Alzheimer's disease among older adults: a scoping review

Hao Z, Du J, Ding X, Shi Y, Wang Z.

Ageing Res Rev. 2025 Aug;110:102800. doi: 10.1016/j.arr.2025.102800. Epub 2025 Jun 14.

Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer's Disease

Verma S, Paliwal S, Paramanick D, Narayan CV, Saini M.

Curr Aging Sci. 2025;18(1):14-28. doi: 10.2174/0118746098299754240530111755.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias